Silence Therapeutics price target lowered to $30 from $31 at Jefferies
PremiumThe FlySilence Therapeutics price target lowered to $30 from $31 at Jefferies
1M ago
Silence Therapeutics reports FY25 net loss  33c vs. 49c loss last year
Premium
The Fly
Silence Therapeutics reports FY25 net loss 33c vs. 49c loss last year
1M ago
Silence Therapeutics extends projected cash runway into 2027
Premium
The Fly
Silence Therapeutics extends projected cash runway into 2027
1M ago
Silence management enthusiastic ahead of catalysts, says H.C. Wainwright
PremiumThe FlySilence management enthusiastic ahead of catalysts, says H.C. Wainwright
2M ago
Silence Therapeutics to Transition to U.S. Issuer Status
Premium
Company Announcements
Silence Therapeutics to Transition to U.S. Issuer Status
3M ago
Silence Therapeutics Advances Promising siRNA Therapy for PV
Premium
Company Announcements
Silence Therapeutics Advances Promising siRNA Therapy for PV
4M ago
Silence Therapeutics Showcases Promising Phase 2 Results
PremiumCompany AnnouncementsSilence Therapeutics Showcases Promising Phase 2 Results
4M ago
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
Premium
The Fly
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
4M ago
Silence Therapeutics: Rising Assets Amid Growing Losses
Premium
Company Announcements
Silence Therapeutics: Rising Assets Amid Growing Losses
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100